Back to Nephrology
Nephrologyv2013Evidence-Based

McMahon Score for Rhabdomyolysis

Predicts mortality or acute kidney injury (AKI) requiring renal replacement therapy in hospitalized rhabdomyolysis patients. The score helps identify low-risk patients unlikely to have severe adverse outcomes.

Clinical Input Parameters

mg/dL
mg/dL
Clinical Assessment
Awaiting Parameters
mcmahon score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The McMahon Score for Rhabdomyolysis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within nephrology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = (Age points) + (Sex points) + (Initial Creatinine points) + (Initial Calcium <7.5 mg/dL points) + (Initial CPK >40,000 U/L points) + (Rhabdo Cause points) + (Initial Phosphate points) + (Initial Bicarbonate <19 mEq/L points)

Clinical Pearls & Practice Notes

  • Known causes include: seizures, syncope, exercise, statins, and myositis (0 points). Other causes score 3 points.
  • Developed for patients with CPK >5,000 U/L within 3 days of admission.
  • A score ≥6 is 68% specific and 86% sensitive for predicting need for RRT.
  • The score helps identify patients who may benefit from aggressive fluid resuscitation early in their course.
  • Initial laboratory values should be obtained on admission or as close to admission as possible.

Evidence & Literature Citations

  1. McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013 Oct 28;173(19):1821-8. doi: 10.1001/jamainternmed.2013.9774.
  2. Safari S, Yousefifard M, Hashemi B, Baratloo A, Forouzanfar MM, Rahmati F, et al. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis. Clin Exp Nephrol. 2016 Apr;20(2):153-61. doi: 10.1007/s10157-015-1204-1.
  3. Premru V, Kovač J, Buturović-Ponikvar J, Ponikvar R. Some kinetic considerations in the treatment of acute kidney injury caused by rhabdomyolysis. Ther Apher Dial. 2017 Oct;21(5):451-456. doi: 10.1111/1744-9987.12547.

Score Interpretation Ranges

Low Risk0 – 5.9 pts

Low risk for death or AKI requiring RRT

Not Low Risk6 – 20 pts

Not low risk for adverse outcomes

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.